Publications by authors named "Eunice Sirri"
Article Synopsis
- - The study analyzed pancreatic neuroendocrine neoplasms (NENs) in Germany from 2009 to 2021, focusing on the incidence and survival rates of neuroendocrine tumors (NETs), neuroendocrine carcinomas (NECs), and mixed neoplasms (MiNEN).
- - It found that the incidence of NETs is rising significantly (16.4% per year), while NECs are declining (6.4% per year), with varying 5-year relative survival rates ranging from 18.5% for MiNEN to 90.3% for functioning NETs.
- - The research concluded that localized or G1 NETs have an excellent prognosis,
Age-standardized cancer incidence has decreased over the last years for many cancer sites in developed countries. Whether these trends led to narrowing or widening socioeconomic inequalities in cancer incidence is unknown. Using cancer registry data covering 48 million inhabitants in Germany, the ecological association between age-standardized total and site specific (colorectal, lung, prostate and breast) cancer incidence in 2007 to 2018 and a deprivation index on district level (aggregated to quintiles) was investigated.
View Article and Find Full Text PDFArticle Synopsis
- A study called CONCORD-3 found that people around the world have very different chances of surviving for five years after being diagnosed with skin cancer, especially certain types of it.
- The researchers wanted to see if the different forms of skin cancer, like nodular and acral melanoma, might explain why these survival rates are so different in various countries.
- They discovered that the survival rates for certain types of melanoma are really high in places like Oceania and North America, but much lower in places like Taiwan, especially for nodular melanoma, which is the hardest type to survive.
Background: Prostate cancer (PCa) is the most frequent cancer among men in Europe. Differences in PCa incidence around the world can be partly explained by variations in recommendations for prostate-specific antigen (PSA), particularly for early detection. For example, the PSA testing policy is more conservative in the Netherlands than in Germany.
View Article and Find Full Text PDFMany countries have reported survival inequalities due to regional socioeconomic deprivation. To quantify the potential gain from eliminating cancer survival disadvantages associated with area-based deprivation in Germany, we calculated the number of avoidable excess deaths. We used population-based cancer registry data from 11 of 16 German federal states.
View Article and Find Full Text PDFBackground: Breast cancer treatment has changed tremendously over the last decades. In addition, the use of mammography screening for early detection has increased strongly. To evaluate the impact of these developments, long-term trends in incidence, mortality, stage distribution and survival were investigated for Germany and the United States (US).
View Article and Find Full Text PDFEvidence on survival of malignant mesothelioma (MM) and other rare thoracic cancers is limited due to the rarity of these cancer sites. Here, we provide a comprehensive overview of MM incidence and survival after MM and other rare thoracic cancers in Germany and the United States (US). Incidence was estimated from a German National Cancer Database and from the Surveillance, Epidemiology and End Results (SEER) 18 database for 2000-2014.
View Article and Find Full Text PDFHepatobiliary tract cancers (HBTCs) are a heterogeneous group of cancers with high mortality. Because most of these cancers, with the exception of hepatocellular carcinoma (HCC), are rare, few data are available concerning the population level survival expectations of patients with HBTC. Here, we describe survival of patients with HBTC in Germany with comparison to survival in the US.
View Article and Find Full Text PDFObjectives: To better understand the influence of prostate-specific antigen (PSA) screening and other health system determinants on prognosis of prostate cancer, up-to-date relative survival (RS), stage distributions, and trends in survival and incidence in Germany were evaluated and compared with the United States of America (USA).
Patients And Methods: Incidence and mortality rates for Germany and the USA for the period 1999-2010 were obtained from the Centre for Cancer Registry Data at the Robert Koch Institute and the USA Surveillance Epidemiology and End Results (SEER) database. For analyses on stage and survival, data from 12 population-based cancer registries in Germany and from the SEER-13 database were analysed.
Objectives: Survival improvement for pancreatic cancer has not been observed in the last 4 decades. We report the most up-to-date population-based relative survival (RS) estimates and recent trends in Germany and the United States.
Methods: Data for patients diagnosed in 1997 to 2010 and followed up to 2010 were drawn from 12 population-based German cancer registries and the US SEER (Surveillance, Epidemiology and End Results) 13 registries database.
Survival of patients with gastric lymphoma in Germany and in the United States.
J Gastroenterol Hepatol
October 2015
Background And Aim: This study aims to examine survival for gastric lymphomas and its main subtypes, mucosa-associated lymphoid tissue lymphoma (MALT), and diffuse large B-cell lymphoma (DLBCL), in Germany and in the United States.
Methods: Data for patients diagnosed in 1997-2010 were used from 10 population-based German cancer registries and compared to the data from the US Surveillance, Epidemiology and End Results (SEER) 13 registries database. Patients age 15-74 diagnosed with gastric lymphomas were included in the analysis.